Sign in
BMRA Stock Price, Chart, Stats & News
Biomerica, Inc.
Save
Biomerica, Inc. (BMRA) does not currently pay a dividend.
7.29M
Market cap
–
Current P/E
–
Forward P/E
BMRA chart
Fundamentals
Gross margin | 5.61% |
Operating margin | -118.10% |
Pretax margin | -90.09% |
Net margin | -90.29% |
Effective tax rate | -0.22% |
ROA | -66.71% |
ROE | -83.73% |
D/E | 0.06x |
Interest coverage ratio | – |
BMRA valuation
P/E | – |
P/S | 1.36x |
P/B | 1.32x |
P/CF | -1.97x |
P/FCF | -2.07x |
P/OCF | -1.97x |
PEG | 0.01x |
EV multiple | -2.27x |
About
Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste.
Similar securities
Based on sector and market capitalization
Report issue